XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 54 filers reported holding XENON PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -10.0% | 252 | 0.0% | 0.00% | – |
| Q2 2023 | $10 | +11.1% | 252 | 0.0% | 0.00% | – |
| Q1 2023 | $9 | -10.0% | 252 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 252 | +27.3% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 198 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 198 | +40.4% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 141 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 141 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 141 | +113.6% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 66 | -60.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 165 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |